Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 21, 2026; 32(43): 120562
Published online Nov 21, 2026. doi: 10.3748/wjg.120562
Published online Nov 21, 2026. doi: 10.3748/wjg.120562
Table 1 Characteristics of the included patients, n (%)/mean ± SD
| Training set | P value | Internal validation set (n = 72) | P value | External validation set (n = 61) | P value | |||
| Total (n = 168) | ER (n = 67) | Non-ER (n = 101) | ||||||
| Patient characteristic | ||||||||
| Age (years) | 56.54 ± 9.56 | 56.15 ± 9.73 | 56.79 ± 9.48 | 0.671 | 56.28 ± 8.73 | 0.84 | 54.95 ± 9.34 | 0.266 |
| Sex | 0.874 | 0.215 | 0.173 | |||||
| Male | 123 (73.2) | 48 (71.6) | 75 (74.3) | 47 (65.3) | 50 (65.3) | |||
| Female | 45 (26.8) | 19 (28.4) | 26 (25.7) | 25 (34.7) | 11 (34.7) | |||
| Etiology | 0.147 | 0.915 | 0.934 | |||||
| HBV | 155 (92.3) | 64 (95.5) | 91 (90.1) | 67 (93.1) | 57 (93.4) | |||
| HCV | 9 (5.4) | 3 (4.5) | 6 (5.9) | 3 (4.2) | 3 (4.9) | |||
| Others | 4 (2.4) | 0 (0.0) | 4 (4.0) | 2 (2.8) | 1 (1.6) | |||
| Tumor characteristics | ||||||||
| Tumor size (cm) | 2.39 ± 0.91 | 2.72 ± 0.91 | 2.18 ± 0.91 | < 0.001 | 2.33 ± 0.81 | 0.651 | 2.46 ± 0.97 | 0.612 |
| No. of tumors | < 0.001 | 0.705 | 0.516 | |||||
| Solitary | 123 (73.2) | 39 (58.2) | 84 (83.2) | 51 (70.8) | 42 (68.9) | |||
| Multiple | 45 (26.8) | 28 (41.8) | 17 (16.8) | 21 (29.2) | 19 (31.1) | |||
| Barcelona Clinic Liver Cancer stage | < 0.001 | 0.702 | 0.862 | |||||
| 0 | 46 (27.4) | 5 (7.5) | 41 (40.6) | 18 (25.0) | 16 (26.2) | |||
| A | 122 (72.6) | 62 (92.5) | 60 (59.4) | 54 (75.0) | 45 (73.8) | |||
| Laboratory index | ||||||||
| AST, IU/L | 36.86 ± 5.25 | 37.00 ± 5.38 | 36.76 ± 5.19 | 0.779 | 36.25 ± 5.22 | 0.408 | 35.19 ± 5.41 | 0.036 |
| ALT, IU/L | 31.01 ± 21.78 | 34.42 ± 23.96 | 28.76 ± 20.01 | 0.099 | 33.12 ± 25.71 | 0.517 | 28.23 ± 15.93 | 0.362 |
| TBIL, μmol/L | 24.59 ± 13.65 | 25.63 ± 14.80 | 23.89 ± 12.87 | 0.423 | 21.34 ± 11.74 | 0.08 | 21.44 ± 12.96 | 0.12 |
| ALB, g/L | 30.78 ± 12.66 | 31.36 ± 10.08 | 30.40 ± 14.14 | 0.634 | 33.43 ± 20.90 | 0.229 | 32.74 ± 10.53 | 0.28 |
| r-GGT (U/L) | 35.78 ± 26.68 | 38.60 ± 31.92 | 33.91 ± 22.52 | 0.266 | 32.01 ± 18.89 | 0.278 | 40.42 ± 29.96 | 0.261 |
| PLT, × 109/L | 110.54 ± 55.67 | 106.62 ± 51.70 | 113.14 ± 58.14 | 0.459 | 112.81 ± 56.08 | 0.774 | 104.41 ± 54.45 | 0.459 |
| Child-Pugh grade | 0.249 | 0.975 | 0.204 | |||||
| A | 121 (72.0) | 47 (70.1) | 74 (73.3) | 52 (72.2) | 49 (80.3) | |||
| B | 47 (29.0) | 20 (29.9) | 27 (26.7) | 20 (27.8) | 12 (19.7) | |||
| AFP, ng/mL | 215.98 ± 351.69 | 329.83 ± 440.58 | 140.44 ± 252.97 | 0.001 | 187.27 ± 331.25 | 0.556 | 294.55 ± 378.51 | 0.144 |
- Citation: Liu T, Wu C, Dong TT, Jia YY, Zhu YY, Wei CM, Duan Y, Li YX, Nie F. Optimal 10-mm window: Integrating peri-ablation radiomics with preoperative features to predict early hepatocellular carcinoma recurrence after thermal ablation. World J Gastroenterol 2026; 32(43): 120562
- URL: https://www.wjgnet.com/1007-9327/full/v32/i43/120562.htm
- DOI: https://dx.doi.org/10.3748/wjg.120562